Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs SHASUN PHARMA - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA SHASUN PHARMA ABBOTT INDIA/
SHASUN PHARMA
 
P/E (TTM) x 47.8 123.9 38.6% View Chart
P/BV x 15.6 8.5 183.1% View Chart
Dividend Yield % 0.4 0.2 188.7%  

Financials

 ABBOTT INDIA   SHASUN PHARMA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-19
SHASUN PHARMA
Mar-14
ABBOTT INDIA/
SHASUN PHARMA
5-Yr Chart
Click to enlarge
High Rs8,83494 9,378.0%   
Low Rs5,45846 11,968.2%   
Sales per share (Unadj.) Rs1,731.1214.2 808.2%  
Earnings per share (Unadj.) Rs211.95.3 3,971.6%  
Cash flow per share (Unadj.) Rs219.915.8 1,389.9%  
Dividends per share (Unadj.) Rs65.001.00 6,500.0%  
Dividend yield (eoy) %0.91.4 63.6%  
Book value per share (Unadj.) Rs945.253.3 1,772.0%  
Shares outstanding (eoy) m21.2556.62 37.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.10.3 1,264.8%   
Avg P/E ratio x33.713.1 257.4%  
P/CF ratio (eoy) x32.54.4 735.5%  
Price / Book Value ratio x7.61.3 576.9%  
Dividend payout %30.718.7 163.7%   
Avg Mkt Cap Rs m151,8483,958 3,836.7%   
No. of employees `0003.5NA-   
Total wages/salary Rs m4,3562,164 201.3%   
Avg. sales/employee Rs Th10,555.5NM-  
Avg. wages/employee Rs Th1,249.9NM-  
Avg. net profit/employee Rs Th1,292.2NM-  
INCOME DATA
Net Sales Rs m36,78612,127 303.3%  
Other income Rs m1,133229 494.0%   
Total revenues Rs m37,91912,356 306.9%   
Gross profit Rs m6,0471,009 599.3%  
Depreciation Rs m169594 28.5%   
Interest Rs m23415 5.4%   
Profit before tax Rs m6,989230 3,042.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,485-73 -3,417.5%   
Profit after tax Rs m4,503302 1,490.6%  
Gross profit margin %16.48.3 197.6%  
Effective tax rate %35.6-31.7 -112.3%   
Net profit margin %12.22.5 491.4%  
BALANCE SHEET DATA
Current assets Rs m27,6106,884 401.0%   
Current liabilities Rs m8,5698,456 101.3%   
Net working cap to sales %51.8-13.0 -399.4%  
Current ratio x3.20.8 395.8%  
Inventory Days Days6062 97.7%  
Debtors Days Days27108 25.5%  
Net fixed assets Rs m1,0574,970 21.3%   
Share capital Rs m213113 187.6%   
"Free" reserves Rs m19,8732,875 691.3%   
Net worth Rs m20,0863,020 665.0%   
Long term debt Rs m01,817 0.0%   
Total assets Rs m29,40913,347 220.3%  
Interest coverage x311.61.6 20,059.7%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x1.30.9 137.7%   
Return on assets %15.45.4 286.4%  
Return on equity %22.410.0 224.1%  
Return on capital %34.913.3 262.0%  
Exports to sales %046.4 0.0%   
Imports to sales %014.2 0.0%   
Exports (fob) Rs mNA5,622 0.0%   
Imports (cif) Rs mNA1,728 0.0%   
Fx inflow Rs m3695,843 6.3%   
Fx outflow Rs m4,9182,173 226.3%   
Net fx Rs m-4,5493,669 -124.0%   
CASH FLOW
From Operations Rs m4,991398 1,255.4%  
From Investments Rs m-2,570-1,635 157.2%  
From Financial Activity Rs m-1,4281,309 -109.1%  
Net Cashflow Rs m99371 1,395.1%  

Share Holding

Indian Promoters % 0.0 39.2 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 3.6 219.4%  
FIIs % 0.1 17.6 0.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 39.6 43.2%  
Shareholders   18,270 20,750 88.0%  
Pledged promoter(s) holding % 0.0 12.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   ORCHID PHARMA  CIPLA  TORRENT PHARMA  ALEMBIC  WYETH  

Compare ABBOTT INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Zooms 450 Points in Opening Trade; Mindtree Up 5% Post Q3 Results(09:30 am)

Asian share markets and US stock futures are trading higher today as investors awaited comments from Joe Biden's Treasury Secretary nominee Janet Yellen on US stimulus and the dollar.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (1QFY21); Net Profit Up 54.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 54.2% YoY). Sales on the other hand came in at Rs 11 bn (up 6.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY20); Net Profit Down 2.0% (Quarterly Result Update)

Jun 9, 2020 | Updated on Jun 9, 2020

For the quarter ended March 2020, ABBOTT INDIA has posted a net profit of Rs 1 bn (down 2.0% YoY). Sales on the other hand came in at Rs 10 bn (up 6.1% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY20); Net Profit Up 59.5% (Quarterly Result Update)

Feb 11, 2020 | Updated on Feb 11, 2020

For the quarter ended December 2019, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 59.5% YoY). Sales on the other hand came in at Rs 11 bn (up 13.8% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

'Essential' Smallcap Stock Recommendations(Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top(Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

A Rare Chance to Invest in Potential Multibaggers in 2021(Profit Hunter)

Jan 11, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Jan 19, 2021 10:56 AM

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 5-YR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS